Cerebellum’s Morgan Stanley MS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$64K Sell
1,326
-235
-15% -$11.8K 0.3% 144
2020
Q2
$82K Buy
+1,561
New +$65.6K 0.06% 355
2019
Q4
Sell
-9,932
Closed -$424K 492
2019
Q3
$424K Buy
9,932
+1,990
+25% +$85K 0.27% 263
2019
Q2
$348K Buy
+7,942
New +$354K 0.28% 167
2019
Q1
Sell
-3,608
Closed -$143K 512
2018
Q4
$143K Hold
3,608
0.1% 357
2018
Q3
$168K Buy
+3,608
New +$176K 0.27% 292
2018
Q2
Sell
-1,228
Closed -$66K 486
2018
Q1
$66K Sell
1,228
-333
-21% -$18.4K 0.08% 384
2017
Q4
$82K Buy
+1,561
New +$78.9K 0.06% 355

Other funds holding MS

Cerebellum's MS Position: Q3 2020 in Review

Cerebellum reduced its Morgan Stanley (MS) stake by 15% in Q3 2020, selling an estimated $11.8K and leaving 1,326 shares worth $64K. The position accounts for 0.3% of the portfolio, ranked #144.

Cerebellum first reported a position in MS in Q4 2017 and has held it in 8 quarters since. The position peaked at $424K in Q3 2019. 1,144 funds tracked by Wall St. Rank hold MS as of Q3 2020.

  • Cerebellum held 1,326 shares of Morgan Stanley worth $64K as of Q3 2020.
  • Cerebellum sold 235 Morgan Stanley shares in Q3 2020, an estimated $11.8K.
  • Morgan Stanley made up 0.3% of Cerebellum's portfolio in Q3 2020, its #144 holding.
  • Cerebellum first reported a position in Morgan Stanley in Q4 2017 and has held it in 8 quarters since.
  • Cerebellum's Morgan Stanley position peaked at $424K in Q3 2019.
  • 1,144 funds tracked by Wall St. Rank held Morgan Stanley as of Q3 2020.

Based on Cerebellum's 13F filing for Q3 2020, filed 21 Oct 2020.